Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence for Ureter Identification in Endometriosis Surgery
NCT07144904Phase 4Not yet recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of indocyanine green in endometriosis (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Operative time for endometriosis resection and ureterolysis. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07144904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07144904.